Xalabrands Xalabrands [Member] Xalabrands Number of restricted stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Document Type Document Type Receivable Type [Axis] Receivable Type [Axis] Awards outstanding, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Other expense (income), net Other Nonoperating Income (Expense) Contingencies Commitments and Contingencies Disclosure [Text Block] Treasury Stock Treasury Stock [Member] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Segments [Axis] Segments [Axis] Pension and Other Postretirement Benefits Disclosure Retirement Benefits [Text Block] Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Weighted average grant-date fair value per share, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Net unrealized gain (loss) on marketable securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent European Commission Proceedings - Perindorpril EU Commission Proceedings Perindorpril [Member] EU Commission Proceedings Perindorpril Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Proceeds from the sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Interest rate swap derivative assets Derivative Asset 2023 Senior Notes (3.125% coupon) SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan Range [Domain] Statistical Measurement [Domain] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Line of Credit [Member] Line of Credit [Member] Yupelri ® Yupelri ® [Member] Yupelri ® Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Non-contingent payments for product rights Payment for Non-Contingent Consideration Liability, Financing Activities Payment for Non-Contingent Consideration Liability, Financing Activities Deferred income tax liability Deferred Income Tax Liabilities, Net Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax Net unrecognized gains (losses) on derivatives, net of tax, beginning of period Net unrecognized gains (losses) on derivatives, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Percentage of fair value in excess of carrying amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Security Exchange Name Security Exchange Name Intangible assets, net Intangible assets, net book value, excluding goodwill Intangible Assets, Net (Excluding Goodwill) Proceeds from issuance of long-term debt Proceeds from Issuance of Long-term Debt (Loss) earnings from operations Operating Income (Loss) Total current liabilities Liabilities, Current 2021 Senior Notes (3.150% coupon) SeniorNotesTwoThousandTwentyOne3.15Precent [Member] 2021 Senior Notes 3.15% Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Diluted (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted 2032 Euro Senior Notes 2032 Euro Senior Notes [Member] 2032 Euro Senior Notes Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current 2043 Senior Notes (5.400% coupon) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Weighted average grant-date fair value per share, nonvested beginning of period Weighted average grant-date fair value per share, nonvested end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Other drug manufacturers Other Companies [Member] Other companies Variable Rate [Domain] Variable Rate [Domain] Viagra ® Viagra ® [Member] Viagra ® Variable Rate [Axis] Variable Rate [Axis] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] ASSETS Assets [Abstract] Investment, Name [Axis] Investment, Name [Axis] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Stock option award vesting period, in years Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Mylan Laboratories Limited Subsidiaries [Member] Defined Benefit Plans, Number of Frozen Plans Defined Benefit Plans, Number of Frozen Plans Defined Benefit Plans, Number of Frozen Plans Entity Address, State or Province Entity Address, State or Province Number of restricted stock awards, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Other comprehensive earnings (loss), before tax Other comprehensive earnings (loss), before tax Other Comprehensive Income (Loss), before Tax Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Program Name [Axis] Program Name [Axis] Program Name Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] 2023 Long-Term Debt, Maturity, Year Three Retained earnings Retained Earnings (Accumulated Deficit) Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Entity Address, Country Entity Address, Country EpiPen® Auto-Injectors EpiPen® Auto-Injectors [Member] EpiPen® Auto-Injectors Other expense Other Expense [Member] Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life North America North America Segment [Member] North America Segment Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Total unrecognized compensation expense, net of estimated forfeitures Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Legal Matters and Contingencies Legal Matters and Contingencies [Text Block] Pension and other postretirement benefits Other Pension, Postretirement and Supplemental Plans [Member] Measurement period adjustments Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Hedging Designation [Domain] Hedging Designation [Domain] Total operating expenses Operating Expenses Building Building [Member] Anticompetitive conduct with respect to additional generic drugs Anticompetitive conduct with respect to additional generic drugs [Member] Anticompetitive conduct with respect to additional generic drugs Restructuring Reserve, Settled without Cash Restructuring Reserve, Settled without Cash Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Common Stock, Par or Stated Value Per Share Ordinary shares, nominal value Common Stock, Par or Stated Value Per Share Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Payments of Financing Costs Payments of Financing Costs Other long-term obligations Other Liabilities, Noncurrent Deferred income tax benefit - noncurrent Deferred Income Tax Assets, Net Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Liability Class [Axis] Liability Class [Axis] Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Work in process Inventory, Work in Process, Net of Reserves Share-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Reconciling items: Segment Reconciling Items [Member] 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Inventories Inventories Inventory, Net Thereafter Long-Term Debt, Maturity, after Year Five Net sales Sales Revenue, Goods, Net Revenue from Contract with Customer, Excluding Assessed Tax Increase in liability for uncertain tax positions Increase in liability for uncertain tax positions Increase in liability for uncertain tax positions Accounts receivable securitization facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Business Acquisition [Axis] Business Acquisition [Axis] Stock option award expiration period, in years Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Recognized net actuarial losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Estimated employer contributions in current year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Upjohn Inc. Upjohn Inc. [Member] Upjohn Inc. [Member] Statement [Line Items] Statement [Line Items] Scenario, Forecast Forecast [Member] Measurement Input, Estimated Tax Rate Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Accrued interest Interest Payable, Current Long-term debt and other noncurrent obligations Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Business Combination, Acquisition Related Costs Business Combination, Acquisition Related Costs Measurement Input Type [Domain] Measurement Input Type [Domain] Other payables Accounts Payable, Other Statement [Table] Statement [Table] Type of Restructuring [Domain] Type of Restructuring [Domain] Interest cost Defined Benefit Plan, Interest Cost Range [Axis] Statistical Measurement [Axis] 2020 Restructuring Plan 2020 Restructuring Plan [Member] 2020 Restructuring Plan Fair value of long-term debt Debt Instrument, Fair Value Disclosure Loss Contingency, Remaining Claims, Number Loss Contingency, Remaining Claims, Number Loss Contingency, Remaining Claims, Number Goodwill impairment measurement input term Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Business Combinations [Abstract] Business Combinations [Abstract] Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Exchange traded funds Exchange Traded Funds [Member] Entity Small Business Entity Small Business Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Unamortized debt issuance expense Unamortized Debt Issuance Expense Debt Debt Disclosure [Text Block] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Measurement Input, Terminal Year Revenue Growth Rate Measurement Input, Terminal Year Revenue Growth Rate [Member] Measurement Input, Terminal Year Revenue Growth Rate Prepaid expenses Prepaid Expense, Current Average remaining contractual term for stock awards exercisable, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Collaborative Arrangement Collaborative Arrangement [Member] Prospective Adoption of New Accounting Pronouncements [Table] Prospective Adoption of New Accounting Pronouncements [Table] Goodwill [Roll Forward] Goodwill [Roll Forward] Amendment Flag Amendment Flag Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V. Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Business Combination [Abstract] Business Combination [Abstract] Number of cases Number of cases Number of cases JANZ Japan, Australia and New Zealand Segment [Member] Japan, Australia and New Zealand Segment Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Utilization Restructuring and Related Cost, Incurred Cost Period [Domain] Period [Domain] [Domain] for Period [Axis] 2020 Revolving Credit Facility 2020 Revolving Credit Facility [Member] 2020 Revolving Credit Facility [Member] Accretion expense Accretion Expense Ordinary shares reserved for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Term Loan Term Loan [Member] Term Loan Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Corporate / Other Corporate, Non-Segment [Member] Other Other Accrued Liabilities, Current Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Other Liabilities, Other than Long-term Debt, Noncurrent Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Equity Method Investments Equity Method Investments [Table Text Block] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Diluted (in shares) Pro Forma Weighted Average Shares Outstanding, Diluted Entity Central Index Key Entity Central Index Key Restructuring Restructuring and Related Activities Disclosure [Text Block] Loss Contingency, Patents Allegedly Infringed, Number Loss Contingency, Patents Allegedly Infringed, Number Derivative Instruments Risk [Axis] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Schedule of Cash, cash equivalents, and restricted cash [Table Text Block] Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] [Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Other long-term obligations Other Noncurrent Liabilities [Member] Components of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Senior Notes Senior Notes [Member] Segments [Domain] Segments [Domain] 2048 Senior Notes (5.200%) SeniorNotesTwoThousandFortyEight [Member] SeniorNotesTwoThousandFortyEight [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Number of equity method investments Number of equity method investments Number of equity method investments Business Acquisition, Pro Forma Net Income (Loss) Business Acquisition, Pro Forma Net Income (Loss) 2024 Long-Term Debt, Maturity, Year Four 2.125% Euro Senior Notes due 2025 2025 Euro Senior Notes [Member] 2025 Euro Senior Notes [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Nonvested Restricted Stock and Restricted Stock Unit Awards Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] 2026 Senior Notes (3.950% coupon) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% Income Statement Location [Axis] Income Statement Location [Axis] Entity Ordinary Shares, Shares Outstanding Entity Common Stock, Shares Outstanding Income Statement Location [Domain] Income Statement Location [Domain] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Change in unrecognized gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Change in unrecognized gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Consolidated Entity Consolidated Entity, Excluding VIE [Member] Selling, general and administrative Selling, General and Administrative Expense Other Other Debt Obligations [Member] Intangible asset amortization expense Amortization of Intangible Assets Amortization of Intangible Assets Foreign currency forward contracts Foreign currency borrowings and forward contracts Foreign Exchange Contract [Member] Note Securitization Facility Note Securitization Facility [Member] Note Securitization Facility [Member] Fair value of financial instruments Derivative, Fair Value, Net Other assets Other assets Other Assets, Noncurrent Equity Method Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Net unrecognized gain (loss) on derivatives Net unrecognized losses on derivatives in net investment hedging relationships, net of tax Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] Segment Information Segment Reporting Disclosure [Text Block] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Trade receivables, net Receivables, Net, Current Total assets Assets 2019 Senior Notes (2.550% coupon) SeniorNotesTwoThousandNineteen [Member] Senior notes two thousand nineteen Scenario [Axis] Scenario [Axis] Intangible asset impairment charges Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Number of restricted stock awards, nonvested beginning of period Number of restricted stock awards, nonvested end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Title of 12(b) Security Title of 12(b) Security Item Effected [Line Items] Item Effected [Line Items] Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Finite-lived intangible assets, net book value Finite-Lived Intangible Assets, Net Senior Notes 2022 Senior Notes 2022 [Member] Senior Notes 2022 Income taxes payable Accrued Income Taxes, Current Subsequent Event Type [Axis] Subsequent Event Type [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Interest expense Interest Expense Other Assets Schedule of Other Assets, Noncurrent [Table Text Block] Other Stockholders' Equity, Other Depreciation and amortization Depreciation, Depletion and Amortization Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets Product and Service [Axis] Product and Service [Axis] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Total liabilities Liabilities Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Tax related items, including contingencies Liability for Uncertainty in Income Taxes, Noncurrent Taxes related to the net share settlement of equity awards Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net Net sales (4) Sales [Member] Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Other Exit Costs Other Restructuring [Member] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Balance Sheet Components Retirement Plan Type [Axis] Retirement Plan Type [Axis] Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] Average remaining contractual term for stock awards vested and expected to vest, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 2022 Long-Term Debt, Maturity, Year Two Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Net earnings (loss) Net (loss) earnings attributable to Viatris Inc. common shareholders Net earnings (loss) Net Income (Loss) Available to Common Stockholders, Basic Level 1 Fair Value, Inputs, Level 1 [Member] Land and improvements Land and Land Improvements [Member] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Inventories Increase (Decrease) in Inventories Rebates, promotional programs and other sales allowances Accrued Sales Allowances Accrued Sales Allowances Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] 2020 Senior Notes (3.750% coupon) Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns Raw materials Inventory, Raw Materials, Net of Reserves Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt 2027 Senior Notes 2027 Senior Notes [Member] 2027 Senior Notes 2024 Euro Senior Notes 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] Debt Instrument [Axis] Debt Instrument [Axis] Additional Paid-In Capital Additional Paid-in Capital [Member] Fair Value Hedging Relationships Fair Value Hedging [Member] Operating Segment Operating Segments [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Asset Class [Axis] Asset Class [Axis] Prepaid Expense and Other Assets [Abstract] Prepaid Expense and Other Assets [Abstract] Shares, Issued Balance (in shares) Balance (in shares) Shares, Issued Litigation Case [Axis] Litigation Case [Axis] Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Machinery and equipment Machinery and Equipment [Member] Fair Value of Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Equity method investments Equity Method Investments Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Multi District Litigation [Member] Multi District Litigation [Member] Multi District Litigation [Member] Earnings before income taxes Operating and non-operating expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Short-term Debt [Line Items] Short-term Debt [Line Items] Adjustments to reconcile net (loss) earnings to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Research and development Research and development Research and Development Expense Senior Notes 2021 Senior Notes 2021 [Member] Senior Notes 2021 Subsequent Event Subsequent Event [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Cash paid for acquisitions, net Payments to Acquire Businesses, Net of Cash Acquired Ordinary shares, shares authorized Common Stock, Shares Authorized Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Property, plant and equipment, gross Property, Plant and Equipment, Gross Proceeds from exercise of stock options Proceeds from Stock Options Exercised Restructuring Plan [Domain] Restructuring Plan [Domain] Schedule of Other Assets [Line Items] Schedule of Other Assets [Line Items] [Line Items] for Schedule of Other Assets [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Corporate costs Corporate costs Corporate costs Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2018 Senior Notes (3.000% coupon) Senior Notes Two Thousand Eighteen - 3.0 Percent [Member] Senior Notes Two Thousand Eighteen - 3.0 Percent Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 2024 Euro Senior Notes, 1.023% 2024 Euro Senior Notes, 1.023% [Member] 2024 Euro Senior Notes, 1.023% Trailing Four Quarters [Member] Trailing Four Quarters [Member] Trailing Four Quarters Measurement Input, Reduction in Terminal Year Revenue Growth Rate Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Current assets: Assets, Current [Abstract] Total intangible asset amortization expense (including impairment charges) Amortization 2046 Senior Notes (5.250% coupon) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Goodwill, gross, beginning balance Goodwill, gross, ending balance Goodwill, Gross Consolidated Entities [Axis] Consolidated Entities [Axis] Comprehensive (loss) earnings Comprehensive Income (Loss), Net of Tax, Attributable to Parent Patents and technologies Patents [Member] Generics Generics [Member] Generics Accounts payable Increase (Decrease) in Accounts Payable, Trade 2021 Long-Term Debt, Maturity, Year One Dimethyl Fumarate Dimethyl Fumarate [Member] Dimethyl Fumarate Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Proceeds from sale of property, plant and equipment Proceeds from Sale of Other Productive Assets Scenario, Unspecified [Domain] Scenario [Domain] Legal Entity [Axis] Legal Entity [Axis] Number of Countries in which Entity Operates Number of Countries in which Entity Operates Counterparty Name [Domain] Counterparty Name [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment City Area Code City Area Code Consolidation Items [Domain] Consolidation Items [Domain] Document Period End Date Document Period End Date Contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Loss Contingency Accrual Loss Contingency Accrual Net Investment Hedging Net Investment Hedging [Member] 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Shares reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Loss from equity method investments Income (Loss) from Equity Method Investments Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Hedging Designation [Axis] Hedging Designation [Axis] Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Accumulated impairment losses, beginning balance Accumulated impairment losses, ending balance Goodwill, Impaired, Accumulated Impairment Loss Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Inventories Schedule of Inventory, Current [Table Text Block] Equity securities Debt Securities, Trading, and Equity Securities, FV-NI Creon ® Creon ® [Member] Creon ® Other comprehensive earnings (loss) before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Share-based Compensation Share-based Payment Arrangement, Noncash Expense Change in short-term borrowings, net Proceeds from (Repayments of) Short-term Debt Entity [Domain] Entity [Domain] Restructuring Reserve, Noncurrent Restructuring Reserve, Noncurrent Other items, net Proceeds from (Payments for) Other Financing Activities Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Designated as Hedging Instrument Designated as Hedging Instrument [Member] Issuance of restricted stock, net of shares withheld Restricted Stock, Value, Shares Issued Net of Tax Withholdings Cover [Abstract] Cover [Abstract] Restructuring charges Restructuring and Related Costs [Table Text Block] Measurement Input Type [Axis] Measurement Input Type [Axis] EpiPen Auto Injector Civil Litigation [Member] EpiPen Auto Injector Civil Litigation [Member] EpiPen Auto Injector Civil Litigation [Member] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Current Portion of Long-Term Debt Current Portion of Long-Term Debt [Member] Number of states Number of states Number of states Basic (in shares) Weighted Average Basic Shares Outstanding, Pro Forma Long-term debt Long-term Debt Goodwill [Line Items] Goodwill [Line Items] Net unrecognized gain (loss) on derivatives Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 2050 Senior Notes 2050 Senior Notes [Member] 2050 Senior Notes Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Available-for-sale fixed income investments Debt Securities [Member] Service cost Defined Benefit Plan, Service Cost U.K. Competition and Markets Authority Proceedings Paroxetine U.K. Competition and Markets Authority Proceedings Paroxetine [Member] U.K. Competition and Markets Authority Proceedings Paroxetine Cost of sales Cost of Goods and Services Sold Available-for-sale securities Debt Securities, Available-for-sale Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Equity Components [Axis] Equity Components [Axis] Finished goods Inventory, Finished Goods, Net of Reserves Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Minimum Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Consolidated Entities [Domain] Consolidated Entities [Domain] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Operating lease liability Operating Lease, Liability, Current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Developed Markets Developed Markets Segment [Member] Developed Markets Segment Other Other Long Term Debt [Member] Other long term debt. Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Modafinil Antitrust Litigation and FTC Inquiry Modafinil Antitrust Litigation and FTC Inquiry [Member] Modafinil Antitrust Litigation and FTC Inquiry. Celebrex ® Celebrex ® [Member] Celebrex ® Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] Asset-backed Securities Asset-backed Securities [Member] Weighted average grant-date fair value per share, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Current assets (excluding inventories and net of cash acquired) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets 2028 Senior Notes [Member] 2028 Senior Notes [Member] 2028 Senior Notes [Member] [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Entity Interactive Data Current Entity Interactive Data Current Corporate Bond Securities [Member] Corporate Bond Securities [Member] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Stock Awards Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Revenue Recognition And Accounts Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Interest rate swaps Interest Rate Swap [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] 2021 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Entity Registrant Name Entity Registrant Name Foreign currency translation adjustment Foreign currency translation adjustment, beginning of period Foreign currency translation adjustment, end of period Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Subsequent Event Type [Domain] Subsequent Event Type [Domain] Derivative [Table] Derivative [Table] Business Acquisition [Line Items] Business Acquisition [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Retirement Plan Type [Domain] Retirement Plan Type [Domain] European Union Commission Proceedings - Citalopram EU Commission Proceedings Citalopram [Member] EU Commission Proceedings Citalopram Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Consolidation Items [Axis] Consolidation Items [Axis] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Not Designated as Hedging Instruments Not Designated as Hedging Instrument [Member] Lyrica ® Lyrica ® [Member] Lyrica ® Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Accounts receivable, net Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Net unrecognized losses and prior service cost related to defined benefit plans, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Pfizer, Inc. Pfizer, Inc. [Member] Pfizer, Inc. [Member] Noncontrolling Interest, Ownership Percentage by Parent Noncontrolling Interest, Ownership Percentage by Parent Beginning Balance Ending Balance Restructuring Reserve Net unrealized gain on marketable securities, net of tax Net unrealized gain (loss) on marketable securities, net of tax, beginning of period Net unrealized gain (loss) on marketable securities, net of tax, end of period AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax Entity Address, Postal Zip Code Entity Address, Postal Zip Code Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Restructuring Type [Axis] Restructuring Type [Axis] Trade Accounts Payable Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Cash payment Payments for Restructuring Basic (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Goodwill Goodwill Goodwill, net, beginning balance Goodwill, net, ending balance Goodwill Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Zoloft ® Zoloft ® [Member] Zoloft ® Document Transition Report Document Transition Report 2040 Senior Notes 2040 Senior Notes [Member] 2040 Senior Notes Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Equivalent percentage of redeemed amount Equivalent Price Percentage Of Principal Amount Redeemable Percentage price equivalent at which long-term debt principal amount is redeemable prior to a specified date. Fair value of financial instruments Derivative Asset, Fair Value, Gross Asset Income taxes Increase (Decrease) in Income Taxes Payable Common Stock, Dividends, Per Share, Declared (in usd per share) Common Stock, Dividends, Per Share, Declared Restricted cash Restricted Cash and Cash Equivalents, Current Proceeds from sale of terminated interest rate swaps Proceeds from Sale of Securities, Operating Activities Level 2 Fair Value, Inputs, Level 2 [Member] 2025 Senior Notes 2025 Senior Notes [Member] 2025 Senior Notes Buildings and improvements Building and Building Improvements [Member] Other current assets Other Assets, Current Chargebacks Chargebacks Chargebacks Country Region Country Region Document Quarterly Report Document Quarterly Report Business Combination, Contingent Consideration, Liability, Measurement Input Business Combination, Contingent Consideration, Liability, Measurement Input Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Asset Class [Domain] Asset Class [Domain] Equity [Abstract] Equity [Abstract] Total assets at recurring fair value measurement Assets, Fair Value Disclosure Loss Contingency, Patents Found Not Infringed, Number Loss Contingency, Patents Found Not Infringed, Number Notional amount of derivative Derivative Asset, Notional Amount Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Measurement Input, Long-term Revenue Growth Rate Measurement Input, Long-term Revenue Growth Rate [Member] Accounts payable Accounts payable Accounts Payable, Trade, Current Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number New Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Derivative Contract Type [Domain] Derivative Contract [Domain] Expected Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Diluted Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Litigation Case Type [Domain] Litigation Case [Domain] Basic (in USD per share) Basic (loss) earnings per share attributable to Viatris Inc. shareholders Earnings Per Share, Basic Foreign currency translation Restructuring Reserve, Translation and Other Adjustment Restructuring and Related Cost, Expected Cost Remaining Restructuring and Related Cost, Expected Cost Remaining Program Name [Domain] Program Name [Domain] [Domain] for Program Name Entity File Number Entity File Number Antitrust Proceedings Antitrust Proceedings [Member] Antitrust proceedings Debt Disclosure [Abstract] Debt Disclosure [Abstract] Other Current Liabilities [Member] Other current liabilities Other Current Liabilities [Member] Number of restricted stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Restructuring Plan [Axis] Restructuring Plan [Axis] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Payments of long-term debt Repayments of Long-term Debt Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Common Stock, Dividends, Per Share, Declared Dividends, Common Stock Vested and expected to vest aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Fair value loss Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Gains and Losses on Marketable Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Counterparty Name [Axis] Counterparty Name [Axis] Common stock Common Stock, Value, Issued Accounts Payable, Current [Abstract] Accounts Payable, Current [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Document Fiscal Year Focus Document Fiscal Year Focus Other long-term assets Other long-term assets Other long-term assets Deferred income tax benefit Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Commercial Paper [Member] Commercial Paper [Member] Short-term Debt [Abstract] Short-term Debt [Abstract] Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Current portion of long-term debt and other long-term obligations Long-term Debt, Current Maturities Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status 2023 Senior Notes (4.200% coupon) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent Current portion of long-term debt Debt, Current Retirement Benefits [Abstract] Retirement Benefits [Abstract] Receivable [Domain] Receivable [Domain] Earnings per Share Policy Earnings Per Share, Policy [Policy Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Weighted average grant-date fair value per share, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Short-term borrowings Short-term Debt Collaboration and Licensing Agreements Collaborative Arrangement Disclosure [Text Block] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Estimated litigation liability Estimated Litigation Liability Xanax ® Xanax ® [Member] Xanax ® Foreign exchange forward contracts Foreign Exchange Forward [Member] Agency mortgage-backed securities Collateralized Mortgage Backed Securities [Member] Trade accounts payable Accounts Payable, Trade Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Amount of fair value in excess of carrying amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Long-term debt Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Interest expense (3) Interest Expense [Member] Accounts receivable Increase (Decrease) in Accounts Receivable Debt Instrument [Line Items] Debt Instrument [Line Items] 2019 Senior Notes (2.500% coupon) SeniorNotesTwoThousandNineteen2.50Precent [Member] 2019 Senior Notes (2.500%) Contingent consideration Contingent Consideration [Member] Contingent Consideration. Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Variable Consideration Variable Consideration [Member] Variable Consideration [Member] 2030 Senior Notes 2030 Senior Notes [Member] 2030 Senior Notes Gain (Loss) on Fair Value Hedges Recognized in Earnings Gain (Loss) on Fair Value Hedges Recognized in Earnings Cash Flow Valuation Technique Valuation Technique, Discounted Cash Flow [Member] Total liabilities and equity Liabilities and Equity Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accumulated other comprehensive loss Accumulated other comprehensive loss, net of tax, beginning of period Accumulated other comprehensive loss, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Entity Address, City or Town Entity Address, City or Town Payroll and employee benefit liabilities Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Period [Axis] Period [Axis] Period [Axis] Restricted stock awards Restricted Stock Units (RSUs) [Member] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Other Assets, Noncurrent [Abstract] Other Assets, Noncurrent [Abstract] Judgment issued Damages awarded Loss Contingency, Damages Awarded, Value Reduction due to lapse in statues Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 2027 Euro Senior Notes 2027 Euro Senior Notes [Member] 2027 Euro Senior Notes Other assets Other Assets [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Product Product [Member] Other non-cash items Other Noncash Income (Expense) Other comprehensive earnings (loss), before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Finite-lived intangible assets, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] Equity Component [Domain] Equity Component [Domain] Cash dividends paid Payments of Dividends Measurement Input, EBITDA Multiple Measurement Input, EBITDA Multiple [Member] Liabilities Liabilities [Abstract] Gross profit Gross loss Gross Profit Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Construction in progress Construction in Progress [Member] Entity Tax Identification Number Entity Tax Identification Number Damages to be paid Loss Contingency, Damages Paid, Value Share-Based Incentive Plan Share-based Payment Arrangement [Text Block] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Other current liabilities Other Liabilities, Current London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Investment, Name [Domain] Investment, Name [Domain] Other comprehensive earnings (loss), net of tax Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Complex GX and Biosimilars Complex GX and Biosimilars [Member] Complex GX and Biosimilars Amitiza ® Amitiza ® [Member] Amitiza ® Emerging Markets Emerging Markets Segment [Member] Emerging Markets Segment Greater China Greater China Segment [Member] Greater China Segment Receivables Facility Receivables Facility [Member] Receivables facility. Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Current Fiscal Year End Date Current Fiscal Year End Date Operating expenses: Operating Expenses [Abstract] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Medicaid and other governmental rebates Medicaid and other governmental rebates Medicaid and other governmental rebates (Loss) earnings per share attributable to Viatris Inc. shareholders Earnings Per Share [Abstract] Earnings Per Share [Abstract] Charges Restructuring Charges Amortization of prior service costs Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Finite-Lived Intangible Assets Finite-Lived Intangible Assets [Member] Defined Benefit Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Measurement Input, Control Premium Measurement Input, Control Premium [Member] Viatris Inc. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Intellectual Property Developed Technology Rights [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Equity method investments summarized financial data basis Equity Method Investments Summarized Financial Data Basis Equity Method Investments Summarized Financial Data Basis Mylan N.V. Mylan Parent Company [Member] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] Litigation settlements and other contingencies, net Litigation settlements and other contingencies, net Gain (Loss) Related to Litigation Settlement Employee benefit liabilities Liability, Defined Benefit Pension Plan, Noncurrent Other receivables Other Receivables, Net, Current Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] 2022 Euro Senior Notes 2022 Euro Senior Notes [Member] 2022 Euro Senior Notes Entity Filler Category Entity Filer Category Common Stock Marketable securities Common Stock [Member] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Product and Service [Domain] Product and Service [Domain] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Lipitor Lipitor ® [Member] Lipitor ® EpiPen Israeli Securities Litigation [Member] EpiPen Israeli Securities Litigation [Member] EpiPen Israeli Securities Litigation [Member] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated U.S. Treasuries US Treasury Securities [Member] Income tax (benefit) provision Other Comprehensive Income (Loss), Tax Other Litigation Other [Member] Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Stated percentage rate Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Brands Brands [Member] Brands Money market funds Money Market Funds [Member] Proceeds from sale and collection of receivables Proceeds from Sale and Collection of Receivables Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Dymista ® Dymista ® [Member] Dymista ® Other Revenues Product and Service, Other [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Reimbursable restructuring charges Restructuring Reserve, Reimbursable Restructuring Charges Restructuring Reserve, Reimbursable Restructuring Charges Acquisitions and Other Transactions Business Combination Disclosure [Text Block] Expected reduction to tax expense by CARES Act Effective Income Tax Rate Reconciliation, CARES Act, Amount Effective Income Tax Rate Reconciliation, CARES Act, Amount Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Business Combination, Provisional Information, Adjustment For Inventory Amortization Business Combination, Provisional Information, Adjustment For Inventory Amortization Business Combination, Provisional Information, Adjustment For Inventory Amortization Number Of Products Number Of Products Number Of Products Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Stock awards Share-based Payment Arrangement, Option [Member] Basis of Accounting Policy Basis of Accounting, Policy [Policy Text Block] Basic Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Basic Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Ownership [Axis] Ownership [Axis] Treasury stock, shares Balance (in shares) Balance (in shares) Treasury Stock, Shares Payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Restructuring Restructuring Reserve, Current Cash Flow Hedging Cash Flow Hedging [Member] Employee Related Costs Employee Severance [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Loss Contingencies [Table] Loss Contingencies [Table] 2025 Long-Term Debt, Maturity, Year Five Ownership [Domain] Ownership [Domain] Plan Name [Domain] Plan Name [Domain] Revenue Recognition and Accounts Receivable Revenue from Contract with Customer [Text Block] Insulin Glargine Insulin Glargine [Member] Insulin Glargine Payments for Business Separation Payments for Business Separation Payments for Business Separation Total equity Balance Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Additional paid-in capital Additional Paid in Capital 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Total revenues Revenues Revenues 2018 Senior Notes (2.600% coupon) Senior Notes Two Thousand Eighteen - 2.6 Percent [Member] Senior Notes Two Thousand Eighteen - 2.6% [Member] Income tax (benefit) provision Income Tax Expense (Benefit) Income Tax Expense (Benefit) Goodwill impairment measurement input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input 2020 Floating Rate Euro Notes 2020 Floating Rate Euro Notes [Member] 2020 Floating Rate Euro Notes Cash, cash equivalents and restricted cash — beginning of period Cash, cash equivalents and restricted cash — end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Product Liability Product Liability [Member] Product Liability Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Purchase of marketable securities Payments to Acquire Marketable Securities Number of defendants Loss Contingency, Number of Defendants Financial and Nonfinancial Liabilities, Fair Value Disclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Issuance of restricted stock, net of shares withheld (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Diluted (in USD per share) Diluted earnings (loss) per ordinary share Earnings Per Share, Diluted Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Local Phone Number Local Phone Number Europe Europe Segment [Member] Europe Segment Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Entity Address, Address Line Three Entity Address, Address Line Three Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Finite-lived Intangible Assets Amortization Expense Finite-lived Intangible Assets Amortization Expense [Table Text Block] Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Summary of Long-Term Debt Schedule of Debt [Table Text Block] Effexor ® Effexor ® [Member] Effexor ® Derivative [Line Items] Derivative [Line Items] Gains and Losses on Derivatives Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Total Long-term Debt, Gross Entity Address, Address Line One Entity Address, Address Line One Other Liabilities, Fair Value Disclosure Other Liabilities, Fair Value Disclosure Entity Address, Address Line Two Entity Address, Address Line Two Norvasc Norvasc ® [Member] Norvasc ® Entity Emerging Growth Company Entity Emerging Growth Company In-process research and development Indefinite-lived Intangible Assets (Excluding Goodwill) Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Business Acquisition, Pro Forma Revenue Business Acquisition, Pro Forma Revenue Deferred income tax expense (benefit) Deferred Income Tax Expense (Benefit) Fair value of financial instruments Derivative Liability, Fair Value, Gross Liability Loss Contingency, Loss in Period Loss Contingency, Loss in Period Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Long-Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Award Type [Axis] Award Type [Axis] Gross sales Revenue from Contract with Customer, Gross Revenue from Contract with Customer, Gross Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Line of Credit Facility, Covenant Terms Line of Credit Facility, Covenant Terms Maximum Maximum [Member] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Cash dividends declared Dividends, Common Stock, Cash Retained Earnings Retained Earnings [Member] Retained Earnings [Member] Contingent consideration payments Payment for Contingent Consideration Liability, Financing Activities Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Average remaining contractual term for stock awards outstanding, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Award Type [Domain] Award Type [Domain] Trading Symbol Trading Symbol Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Measurement Input, Increase in Discount Rate Measurement Input, Increase in Discount Rate [Member] Measurement Input, Increase in Discount Rate 2016 Revolving Credit Facility 2016 Senior Revolving Credit Facility [Member] 2016 Senior Revolving Credit Facility [Member] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] (Loss) Earnings per Share Earnings Per Share [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Financial Instruments and Risk Management Financial Instruments Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Segment Reporting Policy Segment Reporting, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Income Tax Contingency [Table] Income Tax Contingency [Table] Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] 2048 Senior Notes [Member] 2048 Senior Notes [Member] 2048 Senior Notes [Member]